Recent NERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:46:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 10:45:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2024 10:21:01 PM
- Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 11/05/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 12:00:18 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/22/2024 11:12:59 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/22/2024 11:09:49 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/22/2024 11:06:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 08:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:53 PM
- Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:01:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:25:30 PM
- Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 05/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:04:42 PM
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 11:30:30 AM
FEATURED COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM